Publication | Closed Access

Long chain analogs of physostigmine as potential drugs for Alzheimer's disease: new insights into the mechanism of action in the inhibition of acetylcholinesterase

Inhibitory ActivityPotential DrugsAlzheimer's DiseaseBiochemistryMedicineDementiaNeuropharmacologyNeurochemical BiomarkersNeuroscienceNew InsightsNeurodegenerationMolecular SubstratePharmacologyNeurochemistryChain AnalogsDrug Discovery